Ozempic (semaglutide) is designed to slow digestion as part of its therapeutic effect. However, in some patients, this slowing appears to progress into severe gastrointestinal motility disorders, including digestive paralysis, bowel shutdown, and long-term inability to tolerate food.

A Motility disorders is a gastrointestinal problem linked to dysfunctional nerves or muscles located in the digestive tract. This disorder disrupts the usual food movement and waste movement. Motility disorders may result in food transferring slowly (such as gastroparesis) or too fast (such as dumping syndrome), causing complications such as pain, constipation, nausea, or trouble swallowing.

Ozempic (semaglutide) may result in motility disorders. When Ozempic significantly slows down gastric emptying this is infamously known as gastroparesis or “stomach paralysis.” Ozempic mimics the GLP-1 hormones, delaying food exiting the stomach, which can lead to severe nausea, vomiting, constipation, and stomach pain. Clinical research studies indicate that up to 1 in 20 first time Ozempic users may suffer from this serious, slow-motility problems. Reduced motility can result in assorted gastrointestinal problems such as vomiting, chronic constipation, and in unusual severe incidences, bowel obstruction or even ileus.

Patients experiencing severe vomiting, intense abdominal pain, or a feeling of being full very quickly should consult their doctor, as these may be signs of a serious motility issue.

As Ozempic prescriptions expanded beyond diabetes into weight loss, reports of serious motility-related injuries have increased, prompting legal scrutiny and inclusion of these injuries in federal GLP-1 ‘class action’ litigation. There are also lawsuits in New Jersey State Court.

Criteria for an Ozempic gastrointestinal problem motility disorder lawsuit:

  1. Took a GLP-1 medication (must be a name brand script / no compound versions) Manufacturer: Novo Nordisk or Elli Lilly,
  2. No weight loss / bariatric surgeries,
  3. No radiation of the abdominal area within 12 months prior to onset of symptoms,
  4. Need date initially prescribed,
  5. Not a compound version.
  6. Must have one of the following diagnosis that required medical treatment or hospitalization (see below):
  7. Must have one of the following gastrointestinal problem diagnosis that required medical treatment or hospitalization:
  • Intestinal / bowel obstruction or blockage, with or without surgical treatment.
  • Severe or permanent stomach paralysis, Ozempic stomach paralysis.
  • Gastroparesis- diagnosed and treated. (A gastric emptying study may be mandated as a result of Judge Marston’s ruling although law firms could accept ozempic lawsuits without study with hospitalization)
  • Persistent vomiting which requires hospitalization and/or seen in the emergency room (ER) for IV fluids.
  • Gastrointestinal GI injury requiring surgery.
  • Severe and ongoing symptoms of nausea, vomiting, diarrhea, constipation or other gastrointestinal issues that are treated with emergency room visits, hospitalizations, multiple physician visits.
  • Neuropathy with Gastroparesis (GP)*** If the neuropathy diagnosis predates the gastroparesis diagnosis then these potential lawsuits will be reviewed by our law firm on a case by case basis!

What Are Motility Disorders?

Motility disorders occur when the muscles and nerves of the digestive tract fail to move food properly, causing it to:

  • move extremely slowly
  • stop moving altogether
  • back up in the stomach or intestines

These conditions are functional, meaning they occur without a physical blockage.

Motility Disorders Reported in Ozempic Users

Reported conditions include:

  • gastroparesis (stomach paralysis)
  • ileus (functional bowel shutdown)
  • severe chronic constipation
  • intestinal dysmotility
  • generalized GI paralysis

Many patients require hospitalization.

Why Ozempic May Contribute to Motility Disorders

Ozempic works by:

  • delaying gastric emptying
  • suppressing appetite
  • altering gut-brain signaling

In some patients, this intended effect may become excessive or prolonged, especially with dose escalation or long-term use.

Symptoms That May Indicate a Serious Problem

Seek medical care if you experience:

  • persistent nausea or vomiting
  • inability to tolerate food
  • abdominal distension
  • constipation lasting days or weeks
  • severe abdominal pain
  • repeated dehydration

Diagnosis and Treatment

Diagnosis often involves:

  • gastric emptying studies
  • abdominal imaging
  • exclusion of mechanical obstruction
  • GI motility testing

Treatment options are limited and may not fully resolve symptoms.

Ozempic Motility Disorder Lawsuits

Ozempic lawsuits involving motility disorders typically allege:

  • inadequate warnings about severe digestive paralysis
  • under-disclosure of long-term GI risks
  • failure to identify high-risk patients

➡️ Related: Motility Disorders

Who May Qualify for a Claim Review

You may qualify if:

  • you used Ozempic, AND
  • you developed severe digestive dysfunction, AND
  • symptoms required hospitalization or persisted long-term

➡️ Start here: File a Claim

Severe motility disorders linked to Ozempic can cause long-lasting digestive disability and significant life disruption. These injuries are now a recognized category in GLP-1 litigation.